TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
8.29
+0.01 (0.12%)
Jul 16, 2025, 1:30 PM CST

TPEX:4157 Revenue

TaiGen Biopharmaceuticals Holdings had revenue of 10.88M TWD in the quarter ending March 31, 2025, with 8.11% growth. This brings the company's revenue in the last twelve months to 151.47M, up 18.86% year-over-year. In the year 2024, TaiGen Biopharmaceuticals Holdings had annual revenue of 150.65M with 22.35% growth.

Revenue (ttm)
151.47M
Revenue Growth
+18.86%
P/S Ratio
39.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.94B

Revenue Chart

Created with Highcharts 11.4.8TPEX:4157 Revenue - Annual23.42M23.42M1.29B1.29B36.23M36.23M123.1M123.1M150.7M150.7M20202021202220232024-250M500M750M1B1B

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024150.65M27.52M22.35%
Dec 31, 2023123.13M86.90M239.87%
Dec 31, 202236.23M-1.26B-97.20%
Dec 31, 20211.29B1.27B5,426.95%
Dec 31, 202023.42M3.11M15.30%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition